Canadian Medical Center Co. reported a net profit of SAR 15.7 million for 2023, compared to SAR 15.65 million a year earlier.
Item | 2022 | 2023 | Change |
---|---|---|---|
Revenues | 81.23 | 100.34 | 23.5 % |
Gross Income | 24.97 | 31.54 | 26.3 % |
Operating Income | 17.26 | 15.90 | (7.9 %) |
Net Income | 15.65 | 15.71 | 0.4 % |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.20 | 0.20 | 0.4 % |
Revenue increased by 23.53% year-on-year to SAR 100 million in 2023 due to expansions in Saudi Arabia.
Net profit was also supported by the increase in operating income. The provision for doubtful debts rose by SAR 5.87 million.
Item | H2 2022 | H2 2023 | Change |
---|---|---|---|
Revenues | 42.31 | 55.13 | 30.3 % |
Gross Income | 12.34 | 17.33 | 40.4 % |
Operating Income | 8.15 | 7.59 | (6.8 %) |
Net Income | 7.72 | 7.71 | (0.1 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.10 | 0.10 | (0.1 %) |
Item | H1 2023 | H2 2023 | Change |
---|---|---|---|
Revenues | 45.22 | 55.13 | 21.9 % |
Gross Income | 14.21 | 17.33 | 21.9 % |
Operating Income | 8.31 | 7.59 | (8.6 %) |
Net Income | 8.00 | 7.71 | (3.7 %) |
Average Shares | 77.00 | 77.00 | - |
EPS (Riyals) | 0.10 | 0.10 | (3.7 %) |
Total shareholders’ equity, no minority interest, stood at SAR 91.83 million by Dec. 31, 2023, compared to SAR 87.01 million a year ago.
Historical Data |
|||
Period |
Revenue (SAR mln) |
Net profit (SAR mln) |
EPS (SAR /share) |
H1 2020 |
29.83 |
8.4 |
0.11 |
H2 2020 |
34.38 |
7.75 |
0.10 |
H1 2021 |
30.18 |
4.96 |
0.06 |
H2 2021 |
40.46 |
9.1 |
0.12 |
H1 2022 |
38.92 |
7.94 |
0.10 |
H2 2022 |
42.31 |
7.71 |
0.10 |
H1 2023 |
45.22 |
8.00 |
0.10 |
H2 2023 |
55.12 |
7.71 |
0.10 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}